T. Rowe Price Associates »

Neurogene shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.8M 123k 22.86

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Tesla Comm Stk (TSLA)
Broadcom Comm Stk (AVGO)
Unitedhealth Group Comm Stk (UNH)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Neurogene

Samsara BioCapital
Rtw Investments
Redmile Group
Casdin Capital
EcoR1 Capital
Baker Bros. Advisors
BlackRock
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Arrowpoint Asset Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Jennison Associates
Octagon Capital Advisors

View all funds holding Neurogene